Synthesis, isolation, and characterization of the adduct formed in the reaction of p-hydroxyphenylacetaldehyde with the amino headgroup of phosphatidylethanolamine and phosphatidylserine

Chemical Research in Toxicology

Volumn 12, Issue 1, 1999, Pages 19-27

  Hazen, Stanley L ^a,c   Heller, Jozsef ^a   Hsu, Fong Fu ^a   D'Avignon, Andre ^a   Heinecke, Jay W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nutrition and Lipid Research   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DERIVATIVE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE;

ARTICLE; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PHOSPHOLIPID METABOLISM; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

ACETALDEHYDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTE MEMBRANE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROLYSIS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT;

EID: 0032937594     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980147s     Document Type: Article

References (59)

1. Esterbauer, H. (1977) Naturally occurring aldehydes and their biological functions. In Aldehydes in biological systems: their natural occurrence and biological activities (Schavenstein, E., Esterbauer, H., and Zollner, H., Eds.) pp 163-201, Prion Limited, London.
2. Witz, G. (1989) Biological interactions of α,β-unsaturated aldehydes. Free Radical Biol. Med. 7, 333-349.
3. Feron, V. J., Til, H. P., de Vrijer, F., Wouterse, R. A., Cassee, F. R., and van Bladeren, P. J. (1991) Aldehydes: Occurrence, carcinogenic potential, mechanisms of action and risk assessment. Mutat. Res. 259, 363-385.
4. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
5. Davies, K. J. A. (1992) Oxidative damage and repair, Pergamon Press, New York.
6. Marnett, L. J. (1994) DNA adducts of α,β-unsaturated aldehydes and dicarbonyl compounds. IARC Sci. Publ. 125, 151-163.
7. Berliner, J. A., and Heinecke, J. W. (1996) The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. Med. 20, 707-727.
8. Brownlee, M. (1991) Glycosylation products as toxic mediators of diabetic complications. Annu. Rev. Med. 42, 159-166.
9. Baynes, J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
10. Bucala, R., and Cerami, A. (1992) Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv. Pharmacol. 23, 1-34.
11. Friedlander, M. A., Wu, Y. C., Elgawish, A., and Monnier, V. M. (1996) Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. J. Clin. Invest. 97, 728-735.
12. Semenkovich, C. F., and Heinecke, J. W. (1997) The mystery of diabetes and atherosclerosis: Time for a new plot. Diabetes 46, 327-334.
13. Stadtman, E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
14. Ames, B. N., Shigenaga, M. K., and Hagen, T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90, 7915-7922.
15. Heinecke, J. W., Rosen, H., and Chait, A. (1984) Iron and copper promote modification of low-density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74, 1890-1894.
16. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., and Steinberg, D. (1984) Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 81, 3883-3887.
17. Haberland, M. E., Cheng, L., and Fong, D. (1988) Malondialdehyde-altered protein occurs in atheroma of watanabe heritable hyperlipidemic rabbits. Science 241, 215-218.
18. Heinecke, J. W. (1997) Mechanisms of oxidative damage of low-density lipoprotein in human atherosclerosis. Curr. Opin. Lipidol. 8, 268-274.
19. Steinberg, D. (1997) Low-density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272, 20963-20966.
20. Rosenfeld, M. E., Palinski, W., Yla-Herttuala, S., Butler, S., and Witztum, J. L. (1990) Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10, 336-349.
21. Rosenfeld, M. E., Khoo, J. C., Miller, E., Parthasarathy, S., Palinski, W., and Witztum, J. L. (1991) Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87, 90-99.
22. Yla-Herttuala, S., Palinski, W., Butler, S. W., Picard, S., Steinberg, D., and Witztum, J. L. (1994) Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14, 32-40.
23. Palinski, W., Horkko, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., and Witztum, J. L. (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low-density lipoprotein in human plasma. J. Clin. Invest. 98, 800-814.
24. Hazen, S. L., Hsu, F.-F., and Heinecke, J. W. (1996) p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes: A chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J. Biol. Chem. 271, 1861-1867.
25. Anderson, M. M., Hazen, S. L., Hsu, F.-F., and Heinecke, J. W. (1997) Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein: A mechanism for the generation of highly reactive α-hydroxy and α,β-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99, 424-432.
26. Hazen, S. L., Hsu, F.-F., d'Avignon, A., and Heinecke, J. W. (1998) Human neutrophils employ myeloperoxidase to convert α-amino acids to a battery of reactive aldehydes: A pathway for aldehyde formation at sites of inflammation. Biochemistry 37, 6864-6873.
27. Hazen, S. L., d'Avignon, A., Hsu, F.-F., and Heinecke, J. W. (1998) Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize α-amino acids to a family of reactive aldehydes: Mechanistic studies identifying labile intermediates along the reaction pathway. J. Biol. Chem. 273, 4997-5005.
28. Klebanoff, S. J. (1980) Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93, 480-489.
29. Harrison, J. E., and Schultz, J. (1976) Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251, 1371-1374.
30. Linder, M. (1992) Nutritional Biochemistry and Metabolism. In Nutritional Biochemistry and Metabolism, p 98, Elsevier Science Publishing Co., Inc., New York.
31. Hazen, S. L., Gaut, J. P., Hsu, F.-F., Crowley, J. R., d'Avignon, A., and Heinecke, J. W. (1997) p-Hydroxyphenylacetaldehyde, the major product of L-tyrosine oxidation by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes, covalently modifies ∈-amino groups of protein lysine residues. J. Biol. Chem. 272, 16990-16998.
32. Bucala, R., Zenji, M., Koschinsky, T., Cerami, A., and Vlassara, H. (1993) Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. U.S.A. 90, 6434-6438.
33. Pamplona, R., Bellmunt, M. J., Portero, M., Riba, D., and Prat, J. (1995) Chromatographic evidence for Amidori product formation in rat liver aminophospholipids. Life Sci. 57, 873-879.
34. Ravandi, A., Kuksis, A., Marai, L., Myher, J. J., Steiner, G., Lewisa, G., and Kamido, H. (1996) Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood. FEBS Lett. 381, 77-81.
35. Ahmed, M. U., Thorpe, S. R., and Baynes, J. W. (1986) Identification of N∈-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 261, 4889-4894.
36. Dunn, J. A., Patrick, J. S., Thorpe, S. R., and Baynes, J. W. (1989) Oxidation of glycated proteins: age-dependent accumulation of N∈-(carboxymethyl)lysine in lens proteins. Biochemistry 28, 9464-9468.
37. Schleicher, E. D., Wagner, E., and Nerlich, A. G. (1997) Increased accumulation of the glycoxidation product N∈-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99, 457-468.
38. Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S., and Horiuchi, S. (1996) N∈-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35, 8075-8083.
39. Requena, J. R., Ahmed, M. U., Fountain, C. W., Degenhardt, T. P., Reddy, S., Perez, C., Lyons, T. J., Jenkins, A. J., Baynes, J. W., and Thorpe, S. R. (1997) Carboxymethylethanolamine, a biomarker of phospholipid modification during Maillard reaction in vivo. J. Biol. Chem. 272, 17473-17479.
40. Hazen, S. L., Hsu, F.-F., Gaut, J. P., Crowley, J. R., and Heinecke, J. W. (1998) Modification of proteins and lipids by myeloperoxidase-derived oxidants. Methods Enzymol. 300, 88-105.
41. Heinecke, J. W., Li, W., Francis, G. A., and Goldstein, J. A. (1993) Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91, 2866-2872.
42. Rakita, R. M., Michel, B. R., and Rosen, H. (1990) Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry 29, 1075-1080.
43. Morita, Y., Iwamoto, H., Aibara, S., Kobayashi, T., and Hasegawa, E. (1986) Crystallization and properties of myeloperoxidase from normal human leukocytes. J. Biochem. 99, 761-770.
44. Markwell, M. A., Haas, S. M., Bieber, L. L., and Tolbert, N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210.
45. Nelson, D. P., and Kiesow, L. A. (1972) Enthalpy of decomposition of hydrogen peroxide by catalase at 25 °C. Anal. Biochem. 49, 474-478.
46. Steck, T. L., and Kant, J. A. (1974) Preparation of impermeable ghosts and inside-out vesicles from erythrocyte membranes. Methods Enzymol. 31, 172-180.
47. Bligh, E. G., and Dyer, W. J. (1956) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
48. Knapp, D. R. (1979) in Handbook of Analytical Derivatization Reactions, pp 485-486, John Wiley & Sons, New York.
49. Heinecke, J. W., Baker, L., Rosen, H., and Chait, A. (1986) Superoxide-mediated modification of low-density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77, 757-761.
50. Steinbrecher, U. P. (1987) Oxidation of human low-density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262, 3603-3608.
51. Schroit, A. J., Tanaka, Y., Madsen, J., and Fidler, I. J. (1984) The recognition of red blood cells by macrophages: role of phosphatidylserine and possible implications of membrane phospholipid asymmetry. Biol. Cell 51, 227-238.
52. Fadok, V. A., Savill, J. S., Haslett, C., Bratton, D. L., Doherty, D. E., Campbell, P. A., and Henson, P. M. (1992) Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol. 149, 4029-4035.
53. Rigotti, A., Acton, S. L., and Krieger, M. (1995) The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270, 16221-16224.
54. Sambrano, G. R., Terpstra, V., and Steinberg, D. (1997) Independent mechanisms for macrophage binding and macrophage phagocytosis of damaged erythrocytes. Evidence of receptor cooperativity. Arterioscler. Thromb. Vasc. Biol. 17, 3442-3448.
55. Terpstra, V., Bird, D. A., and Steinberg, D. (1998) Evidence that the lipid moiety of oxidized low-density lipoprotein plays a role in its interaction with macrophage receptors. Proc. Nail. Acad. Sci. U.S.A. 95, 1806-1811.
56. Daugherty, A., Dunn, J. L., Rateri, D. L., and Heinecke, J. W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444.
57. Hazen, S. L., and Heinecke, J. W. (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99, 2075-2081.
58. Leeuwenburgh, C., Hardy, M. M., Hazen, S. L., Wagner, P., Ohishi, S., Steinbrecher, U. P., and Heinecke, J. W. (1997) Reactive nitrogen intermediates promote low-density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272, 1433-1436.
59. Leeuwenburgh, C., Rasmussen, J. E., Hsu, F.-F., Mueller, D. M., Pennathur, S., and Heinecke, J. W. (1997) Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low-density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272, 3520-3526.